Bispecific Antibodies for Lymphoma What Does the Future Look Like for the Promising Targeted Therapy?

When it comes to treating non-Hodgkin lymphoma, bispecific antibodies are a unique targeted therapy that essentially attack cancer on two fronts and recent approvals mean more patients have access.